Incidence and risk factors for herpes zoster in patients undergoing liver transplantation

被引:27
|
作者
Hamaguchi, Y. [1 ]
Mori, A. [1 ]
Uemura, T. [1 ]
Ogawa, K. [1 ]
Fujimoto, Y. [1 ]
Okajima, H. [1 ]
Kaido, T. [1 ]
Uemoto, S. [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg, Kyoto 6068507, Japan
关键词
herpes zoster; liver transplantation; incidence rate; risk factors; mycophenolate mofetil; MYCOPHENOLATE-MOFETIL; POSTHERPETIC NEURALGIA; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; VARICELLA; METAANALYSIS; INFECTION; GRAFT; CYTOMEGALOVIRUS; COMPLICATIONS;
D O I
10.1111/tid.12425
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundHerpes zoster (HZ) is the most common manifestation of latent varicella zoster virus reactivation, which occurs naturally as a result of aging or in immunocompromised patients. Solid organ transplant recipients are at increased risk for HZ owing to their chronic immunosuppression. Although several reports investigated risk factors for the development of HZ in heart or renal transplantation, data in liver transplantation (LT) are limited. MethodsWe evaluated clinical data retrospectively in 377 adult patients undergoing LT between January 2005 and December 2012 in our institution. We analyzed the incidence rate of HZ and the standardized incidence ratio (SIR) by comparing with the general Japanese population. We additionally investigated risk factors for HZ after LT. ResultsHZ developed in 27 (7.16%) of the 377 patients after LT. The incidence rate of HZ after LT was 17.83 per 1000 person-years, which was significantly higher than in the general Japanese population (SIR = 4.61; 95% confidence interval [CI], 4.13-5.14). Multivariate analysis showed that older age (hazard ratio [HR] = 3.95; P < 0.001) and exposure to mycophenolate mofetil (HR = 3.03; P = 0.007) were independent risk factors for HZ after LT. ConclusionsThis is the first and largest study, to our knowledge, to investigate the incidence rate of HZ and risk factors for development of HZ after LT in the Japanese population. Further investigations to focus on immunosuppressive regimens to reduce the risk for HZ incidence in this high-risk population could establish a new protocol of immunosuppression after LT.
引用
收藏
页码:671 / 678
页数:8
相关论文
共 50 条
  • [1] Incidence and Risk Factors for Herpes zoster after Liver Transplantation
    Kim, W.
    [J]. TRANSPLANTATION, 2017, 101 (05) : 325 - 325
  • [2] Herpes zoster after liver transplantation: Incidence, risk factors, and complications
    Herrero, JI
    Quiroga, J
    Sangro, B
    Pardo, F
    Rotellar, F
    Alvarez-Cienfuegos, J
    Prieto, J
    [J]. LIVER TRANSPLANTATION, 2004, 10 (09) : 1140 - 1143
  • [3] Incidence and risk factors for herpes zoster after adult liver transplantation
    Kim, Wontae
    Kim, Sangjin
    Oh, Jongwook
    Jeong, Young Jae
    Rhu, Jinsoo
    Kim, Kyung Sik
    Lee, Jisoo
    Choi, Gyu-Sung
    Kim, Jong Man
    Joh, Jae-Won
    [J]. ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2019, 96 (02) : 95 - 99
  • [4] Herpes Zoster after liver transplantation. Incidence, risk factors and complications
    Herrero, JI
    Quiroga, J
    Sangro, B
    Pardo, F
    Rotellar, F
    Cienfuegos, JA
    Prieto, J
    [J]. LIVER TRANSPLANTATION, 2004, 10 (06) : C42 - C42
  • [5] Incidence and risk factors for herpes zoster following heart transplantation
    Koo, S.
    Gagne, L. S.
    Lee, P.
    Pratibhu, P. P.
    James, L. M.
    Givertz, M. M.
    Marty, F. M.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (01) : 17 - 25
  • [6] Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors
    Kho, Marcia M. L.
    Roest, Stefan
    Bovee, Dominique M.
    Metselaar, Herold J.
    Hoek, Rogier A. S.
    van der Eijk, Annemiek A.
    Manintveld, Olivier C.
    Roodnat, Joke I.
    van Besouw, Nicole M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] Herpes zoster in SLE: prevalence, incidence and risk factors
    Kwan, Andrew
    Al Rayes, Hanan
    Lazova, Tijana
    Anderson, Nicole
    Bonilla, Dennisse
    Su, Jiandong
    Touma, Zahi
    [J]. LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [8] Incidence and Risk Factors for Herpes Zoster in Rheumatoid Arthritis Patients Receiving Upadacitinib
    Winthrop, Kevin
    Nash, Peter
    Yamaoka, Kunihiro
    Mysler, Eduardo
    Calabrese, Leonard
    Khan, Nasser
    Enejosa, Jeffrey
    Song, Yanna
    Suboticki, Jessica
    Curtis, Jeffrey
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease
    Gupta, Gauree
    Lautenbach, Ebbing
    Lewis, James D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S425 - S425
  • [10] INCIDENCE AND RISK FACTORS FOR HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING UPADACITINIB
    Winthrop, K.
    Nash, P.
    Yamaoka, K.
    Mysler, E.
    Calabrese, L.
    Khan, N.
    Enejosa, J. J.
    Song, Y.
    Suboticki, J.
    Curtis, J. R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 331 - 332